27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2016-11-27T09:58:58+01:00 Read More
25 11, 2016 Laura Capelli et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports Diatech Pharmacogenetics2017-08-08T12:52:59+02:00 Read More
12 11, 2016 Greta Alì et al., Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncology Letters Diatech Pharmacogenetics2016-11-12T10:15:40+01:00 Read More
12 11, 2016 Caterina Marchiò et al., Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept. Neuro-Oncology Diatech Pharmacogenetics2016-11-12T08:56:32+01:00 Read More
8 11, 2016 Federico Pessina et al., Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology Diatech Pharmacogenetics2016-11-08T10:06:17+01:00 Read More
8 11, 2016 Harriet Johansson et al., Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research Diatech Pharmacogenetics2017-08-08T12:52:02+02:00 Read More
26 10, 2016 Annemarie Boleij et al., RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:50:49+02:00 Read More
11 10, 2016 Giovanna De Maglio et al., Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:56:40+02:00 Read More
11 10, 2016 Annarita Destro et al., The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology Diatech Pharmacogenetics2017-08-07T16:00:55+02:00 Read More
11 10, 2016 Elisa Chiadini et al., Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:41:59+02:00 Read More
